Details for New Drug Application (NDA): 209011
✉ Email this page to a colleague
The generic ingredient in MONTELUKAST SODIUM is montelukast sodium. There are thirty-five drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the montelukast sodium profile page.
Summary for 209011
Tradename: | MONTELUKAST SODIUM |
Applicant: | Rising |
Ingredient: | montelukast sodium |
Patents: | 0 |
Pharmacology for NDA: 209011
Mechanism of Action | Leukotriene Receptor Antagonists |
Suppliers and Packaging for NDA: 209011
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MONTELUKAST SODIUM | montelukast sodium | TABLET, CHEWABLE;ORAL | 209011 | ANDA | Graviti Pharmaceuticals Private Limited | 69844-074 | 69844-074-01 | 30 TABLET, CHEWABLE in 1 BOTTLE (69844-074-01) |
MONTELUKAST SODIUM | montelukast sodium | TABLET, CHEWABLE;ORAL | 209011 | ANDA | Graviti Pharmaceuticals Private Limited | 69844-074 | 69844-074-02 | 100 TABLET, CHEWABLE in 1 BOTTLE (69844-074-02) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, CHEWABLE;ORAL | Strength | EQ 4MG BASE | ||||
Approval Date: | Apr 18, 2017 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, CHEWABLE;ORAL | Strength | EQ 5MG BASE | ||||
Approval Date: | Apr 18, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription